Haploidentical stem cell transplantation for children with high-risk leukemia

Pediatric Blood and Cancer

Volumn 59, Issue 5, 2012, Pages 895-901

  Palma, Julia ^a,b   Salas, Lucia ^a   Carrión, Flavio ^c   Sotomayor, Cristián ^a   Catalán, Paula ^a   Paris, Claudia ^a   Turner, Victoria ^d   Jorquera, Hugo ^e   Handgretinger, Rupert ^f   Rivera, Gastón K ^d  

^a HOSPITAL LUIS CALVO MACKENNA   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSIDAD DE LOS ANDES   (Chile)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e Biogenetics Laboratory   (Chile)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Ethnic minorities; Haploidentical; Hematopoietic stem cell transplantation; Leukemia

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHYLPREDNISOLONE; OSELTAMIVIR; PREDNISONE; RITUXIMAB; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOVIRUS INFECTION; ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD DONOR; CANCER PATIENT; CANCER RELAPSE; CAUSE OF DEATH; CHILD; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HAPLOIDY; HIGH RISK PATIENT; HOSPITALIZED CHILD; HUMAN; HUMAN CELL; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; SERUM SICKNESS; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; T CELL DEPLETION; TOXOPLASMOSIS; TREATMENT RESPONSE; TUBERCULOSIS; TUMOR ENGRAFTMENT; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHILE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA; LIVING DONORS; MALE; REGISTRIES; RISK FACTORS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84865389160     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24022     Document Type: Article

References (47)

1. Ljungman P, Bregni M, Brune M, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumour and immune disorders: Current practice in Europe 2009. Bone Marrow Transplant 2010; 45: 219-234.
2. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 2004; 32: 397-407.
3. Hough R, Cooper N, Veys P. Allogeneic haemopoietic stem cell transplantation in children: What alternative donor should we choose when no matched sibling is available? Br J Haematol 2009; 147: 593-613.
4. Lanino E, Sacchi N, Peters C, et al. Strategies of the donor search for children with second CR ALL lacking a matched sibling donor. Bone Marrow Transplant 2008; 41: S75-S79.
5. Eapen M, Rubinstein P, Zhang MJ, et al. Comparable long-term survival alter unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 2006; 24: 145-151.
6. Dahlke J, Kröger N, Zabelina T, et al. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation. Bone Marrow Transplant 2006; 37: 155-163.
7. Barker JN, Rocha V, Scaradavou A. Optimizing unrelated donor cord blood transplantation. Biol Blood Marrow Transplant 2009; 15: 154-161.
8. Sauter C, Barker JN. Unrelated donor umbilical cord blood transplantation for the treatment of hematologic malignancies. Curr Opin Hematol 2008; 1: 568-575.
9. Palma J, Mosso C, Paris C, et al. Establishment of a pediatric HSCT program in a public hospital in Chile. Pediatr Blood Cancer 2006; 46: 803-810.
10. Lange P, Greila J, Bader P, et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 2004; 33: 281-287.
11. Klingebiel T, Lang P, Schumm M, et al. Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. Pathol Biol (Paris) 2005; 53: 159-161.
12. Blume K, Krance R. The evaluation and counseling of candidates for hematopoietic cell transplantation. In: Appelbaum F, Forman S, Negrin R, Blume K, editors. Thomas' hematopoietic cell transplantation, 4th edition. Chichester, UK: Wiley-Blackwell; 2009. pp 445-460.
13. Sacchi N, Costeas P, Hartwell L, et al. Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Bone Marrow Transplant 2008; 42: 9-14.
14. Leung W, Iyengar R, Triplett B, et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 2005; 174: 6540-6545.
15. Stern M, Ruggeri L, Mancusi A, et al. Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. Blood 2008; 112: 2990-2995.
16. Dykes JH, Toporski J, Juliusson G, et al. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults. Transfusion 2007; 47: 2134-2142.
17. Bethge WA, Faul C, Bornhäuser M, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update. Blood Cells Mol Dis 2008; 40: 13-19.
18. Nitsche A, Steuer N, Schmidt CA, et al. Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DN. Clin Chem 1999; 45: 1932-1937.
19. Schaade L, Kockelkorn P, Ritter K, Keines M. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. J Clin Microbiol 2000; 38: 4006-4009.
20. Stöcher M, Leb V, Bozic M, et al. Parallel detection of five human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run. J Clin Virol 2003; 26: 85-93.
21. Schalasta G, Eggers M, Schmid M, et al. Analysis of human cytomegalovirus DNA in urines of newborns and infants by means of a new ultrarapid real-time PCR system. J Clin Virol 2000; 19: 175-185.
22. Comey CT, Budowle B. Validation studies on the analysis of the HLA DQ alpha locus using the polymerase chain reaction. J Forensic Sci 1991; 36: 1633-1648.
23. Sambrook J, Russell D, editors. Molecular cloning: A laboratory manual, 3rd edition. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 2001.
24. Bader P, Kreyenberg H. Analysis of chimerism after stem cell transplantation. In: Goulden NJ, Stewars CG, editors. Pediatric hematology: Methods and protocols. Totowa, NJ: Humana Press, Inc., 2004. pp 247-262.
25. Kristt D, Israeli M, Narinski R, et al. Hematopoietic chimerism monitoring based on STRs: Quantitative platform performance on sequential samples. J Biomol Tech 2005; 16: 378-389.
26. Balon J, Hałaburda K, Bieniaszewska M, et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant 2005; 35: 1083-1088.
27. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112: 973-980.
28. Creutzig U, Zimmermann M, Ritter J, et al. Definition of a standard-risk group in children with AML. Br J Haematol 1999; 104: 630-639.
29. Wang S, Ray N, Rojas W, et al. Geographic patterns of genome admixture in Latin American Mestizos. PLoS Genet 2008; 4: e1000037.
30. Johansen KA, Schneider JF, McCaffree MA, et al. Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors. Transfus Med 2008; 18: 250-259.
31. Klingebiel T, Cornish J, Labopin M, et al. Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: Impact of center size. Blood 2010; 115: 3437-3446.
32. Gordon PR, Leimig T, Mueller I, et al. A large-scale method for T cell depletion: Towards graft engineering of mobilized peripheral blood stem cells. Bone Marrow Transplant 2002; 30: 69-74.
33. Schumm M, Handgretinger R, Pfeiffer M, et al. Determination of residual T- and Bcell content after immunomagnetic depletion: Proposal for flow cytometric analysis and results from 103 separations. Cytotherapy 2006; 8: 465-472.
34. Barfield RC, Otto M, Houston J, et al. A one-step large-scale method for T- and Bcell depletion of mobilized PBSC for allogeneic transplantation. Cytotherapy 2004; 6: 1-6.
35. Leung W, Iyengar R, Turner V, et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004; 172: 644-650.
36. Aversa F, Terenzi A, Felicini R, et al. Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia. Bone Marrow Transplant 1998; 22: S29-S32.
37. Peters C, Matthes-Martin S, Fritsch G, et al. Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: Evaluation of early monitoring of engraftment. Leukemia 1999; 13: 2070-2078.
38. Ortin M, Raj R, Kinning E, et al. Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and antilymphocyte gamma-globulin. Bone Marrow Transplant 2002; 30: 359-366.
39. Lang P, Greil J, Bader P, et al. Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 2004; 33: 281-287.
40. Handgretinger R, Chen X, Pfeiffer M, et al., Feasibility and outcome of reduced intensity conditioning in haploidentical transplantation. Ann NY Acad Sci 2007; 1106: 279-289.
41. Chen X, Hale GA, Barfield R, et al. Rapid immune reconstitution after a reduced intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 2006; 135: 524-532.
42. Kuijpers TW, Baars PA, Dantin C, et al. Human NK cells can control CMV infection in the absence of T cells. Blood 2008; 112: 914-915.
43. Paris C, Kopp K, King A, et al. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile. Pediatr Blood Cancer 2009; 53: 453-458.
44. Amrolia PJ, Muccioli-Casadei G, Huls H, et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 2006; 108: 1797-1808.
45. Leen AM, Christin A, Myers GD, et al. Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 2009; 114: 4283-4292.
46. Olson JA, Leveson-Gower DB, Gill S, et al. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. Blood 2010; 115: 4293-4301.
47. Lang P, Handgretinger R. Haploidentical SCT in children: An update and future perspectives. Bone Marrow Transplant 2008; 42: S54-S59.